Park Ha Biological Technology Co., Ltd. (BYAH) Form 6-K — Jul 24, 2026
Park Ha Biological Technology reported unaudited financial results for the six months ended April 30, 2026, showing a net loss of $918,282 compared to a loss of $19.8 million in the prior year period. The significant 95% reduction in net loss was primarily driven by the absence of the prior year's share-based payment expense and a shift in revenue mix, although total revenue remained relatively flat at $1.26 million. The company's business model underwent a strategic pivot, with revenue from direct product sales to non-franchisees surging 188% to $600,022 while franchise fees declined 35% due to a reduction in the franchise network from 39 to 21 partners.
Key figures
- Revenue
- 1257689
- Cash Position
- 627851
- Shares Outstanding
- 4924884
- Reverse split ratio
- 1-for-50
- Franchisee count prior
- 39
- Franchisee count current
- 21
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.